ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs MXN
16.80482
0.06%
Brent Oil
84.065
0.14%
Bitcoin
62,902.05
-0.23%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. JanOne Inc (JAN)

  7. JanOne Inc (JAN) Noticias

JAN

JanOne (JAN)

JanOne Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:JAN
FechaHoraFuenteTítuloSímboloCompañía
06/05/202415:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
06/05/202415:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:JANJanOne Inc
15/03/202408:00PR Newswire (US)JanOne Regains Compliance with Nasdaq's Listing RequirementsNASDAQ:JANJanOne Inc
09/02/202411:36Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:JANJanOne Inc
21/09/202310:30PR Newswire (US)JanOne to Present at the Dawson James 8th Annual Investment ConferenceNASDAQ:JANJanOne Inc
21/09/202308:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:JANJanOne Inc
31/08/202312:30PR Newswire (US)JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment ConferenceNASDAQ:JANJanOne Inc
29/08/202312:30PR Newswire (US)JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic PainNASDAQ:JANJanOne Inc
28/08/202316:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:JANJanOne Inc
25/08/202313:30PR Newswire (US)JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual MeetingNASDAQ:JANJanOne Inc
24/08/202315:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:JANJanOne Inc
22/08/202316:30PR Newswire (US)JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:JANJanOne Inc
18/08/202318:00PR Newswire (US)JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:JANJanOne Inc
18/08/202311:42PR Newswire (US)JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual MeetingNASDAQ:JANJanOne Inc
16/08/202314:55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JANJanOne Inc
15/08/202315:39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:JANJanOne Inc
28/06/202307:30PR Newswire (US)JanOne files international patent application for methods of using low dose naltrexone to treat chronic painNASDAQ:JANJanOne Inc
22/05/202315:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:JANJanOne Inc
11/05/202315:31Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:JANJanOne Inc
21/04/202315:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JANJanOne Inc
18/04/202307:30PR Newswire (US)JanOne Completes Pre-IND Meeting with FDA on Jan123NASDAQ:JANJanOne Inc
17/04/202315:58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:JANJanOne Inc
13/04/202307:30PR Newswire (US)JanOne to Present Data On Its Two Non-Opioid Drug Candidates at The Appalachian Region Spine and Pain Meeting on Drug Development Programs to Treat Pain on April 15, 2023NASDAQ:JANJanOne Inc
27/03/202308:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JANJanOne Inc
24/03/202310:02PR Newswire (US)JanOne Technologies Announces Closing of Registered Direct Offering of Common Stock Priced At-The-MarketNASDAQ:JANJanOne Inc
24/03/202309:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:JANJanOne Inc
23/03/202307:30PR Newswire (US)JanOne Welcomes John Bonfiglio -- Veteran Biotech Executive, Deal Maker and Strategist -- to Top Management TeamNASDAQ:JANJanOne Inc
23/03/202307:00PR Newswire (US)JanOne Technologies Announces Registered Direct Offering of Common Stock Priced At-The-MarketNASDAQ:JANJanOne Inc
22/03/202307:30PR Newswire (US)JanOne Sells Legacy Business ARCA Recycling to Concentrate on Growing BioPharm BusinessesNASDAQ:JANJanOne Inc
20/03/202305:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:JANJanOne Inc
 Showing the most relevant articles for your search:NASDAQ:JAN

Su Consulta Reciente

COIN
ETHUSD
Ethereum
COIN
BTCUSD
Bitcoin
PM
XAUUSD
Gold vs US Dollar
USOTC
ADDYY
Adidas (QX)
NYSE
KO
Coca Cola
AMEX
SPY
SPDR S&P 500
NYSE
XOM
Exxon Mobil
CCOM
US500
US 500
USI
USTECH100
US Tech 100
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
MSFT
Microsoft
FX
EURMXN
Euro vs MXN
CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados